PD2M AI For Pharma Conference | AIChE

We are very excited to announce the PD2M AI For Pharma Conference.The conference objective is to serve as a vibrant forum for practitioners and stakeholders for sharing innovative applications of AI/ML to challenges in drug development, process development, manufacturing and regulatory submissions and accelerating adoption of AI/ML tools across the drug development lifecycle. This will include applications of AI/ML in small-molecule/biologics discovery, drug substance/drug product process development, manufacturing, and external perspectives from biopharm adjacent technology partners. 

The program will include Keynote speakers, technial sessions, and panel discussions.

Scientists, data scientists, engineers, managers, business professionals and academics who develop or use AI/ML applied to biopharmaceutical discovery, development, and manufacturing are invited to participate.

In-Person Event

Venue:
Amgen, Cambridge MA
360 Binney St. Cambridge, MA 02142 USA

Hotel Information: AIChE provides this list of local hotels available at market price, as a courtesy to meeting attendees:

Hotel name Address Telephone Walking Time
Boston Marriott Cambridge 50 Broadway, Cambridge, MA   02142 USA (617) 494-6600 10 minutes
Residence Inn by Marriott Boston Cambridge 120 Broadway, Cambridge, MA   02142 USA (617) 349-0700 7 minutes
Royal Sonesta Boston 40 Edwin H. Land Blvd. Cambridge MA 02142USA (617) 806-4200 20 minutes
Kimpton Marlowe Hotel 25 Edwin H. Land Blvd. Cambridge MA 02141 USA (617) 868-8000 20 Minutes
Holiday Inn  Express Boston-Cambridge 250 Monsignor O'Brien Pkwy. Cambridge MA 02141 USA (617) 577-7600 25 Minutes
Fairfield Inn by Marriott Boston-Cambridge 215 Monsignor O'Brien Pkwy. Cambridge MA 02141 USA (617) 621-1999 25 Minutes
Hampton Inn Boston-Cambridge 191 Monsignor O'Brien Pkwy. Cambridge MA 02141 USA (617) 494-5300 25 Minutes

Topics

  • Application of Artificial Intelligence (AI) and Machine Learning (ML) to Discovery of Biological Therapeutics

  • Application of Artificial Intelligence (AI) and Machine Learning (ML) to Discovery of Small Molecule Therapeutics

  • Integration of Artificial Intelligence (AI) and Machine Learning (ML) into drug substance process development and manufacturing

  • Regulatory Panel Discussion

  • External Panel Discussion